Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

15

Revenue 2017

Novo Nordisk

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.

Novo Nordisk

Novo Nordisk enters new research alliance for diabetes and cardiometabolic diseases

Novo Nordisk enters new research alliance for diabetes and cardiometabolic diseases

Novo Nordisk and the Broad Institute of MIT and Harvard have announced a new research alliance to address ‘critical unmet clinical needs’ in diabetes and cardiometabolic diseases. ... The Novo side of the collaboration is secured through the Novo

Eli Lilly’s Mounjaro receives NICE recommendation to treat type 2 diabetes

Eli Lilly’s Mounjaro receives NICE recommendation to treat type 2 diabetes Evidence from clinical trials showed that Mounjaro resulted in significant reductions in blood sugar levels and body weight in comparison to Novo Nordisk’s semaglutide injection, insulin therapy or a placebo.

Boehringer and Lilly’s Jardiance granted MHRA approval to treat chronic kidney disease

Boehringer and Lilly’s Jardiance granted MHRA approval to treat chronic kidney disease The deal gives Lilly access to Versanis' lead asset, bimagrumab, a monoclonal antibody currently being assessed in a mid-stage trial as both a monotherapy and in combination with Novo

Novo Nordisk acquires Embark Biotech in deal worth over €470m

Novo Nordisk acquires Embark Biotech in deal worth over €470m Novo Nordisk has announced its acquisition of Embark Biotech in a deal worth over 470m, marking another expansion of the Danish drugmaker’s cardiometabolic disease pipeline. ... We are thrilled to pass on the baton for our lead metabolic programme to

US government announces first ten drugs subject to Medicare pricing negotiations

US government announces first ten drugs subject to Medicare pricing negotiations Boehringer Ingelheim's Jardiance (empagliflozin) and Novo Nordisk's Novolog/Fiasp (insulin aspart).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical education website. Support...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....